Literature DB >> 27407382

Role of Molecular Typing in Live Related Donor Renal Transplantation.

G S Chopra1, R N Diwan2, N K Mehra3.   

Abstract

In renal transplantation, a good HLA-DR match is associated with higher success rate of graft outcome. It is particularly so In high risk recipients. Serological HLA-DR typing is not always easy due to a number of technical problems. In view of this, a comparison of serological and molecular typing was done in our institutions. A total of 64 live related donor patients of renal transplantation were studied. Serological typing was done by conventional methods. Molecular HLA class II typing was done by polymerase chain reaction (PCR) based sequence specific oligonucleotide probe (SSOP) hybridization technique. An overall discrepancy of 19.5% was observed in the DR typing obtained by serology and PCR-SSOP of all the recipients and donors. 14.5% of cases showed discrepancy in the results of only one DR antigen. Serological typing failure was seen in 10.9% of total cases. In 19.5% cases, only one DR antigen was assigned by PCR-SSOP as compared to two antigens by serological methods. Maximum number of discrepancies were seen in DR 2 antigens. There was no appreciable difference of graft survival shown in the patients typed by both methods. However, higher incidence of acute graft rejection episodes were seen in patients with 1 antigen mismatch as compared to zero mismatch. It is concluded that HLA-DR typing should be carried out by molecular methods as these have been found to be more specific and accurate.

Entities:  

Keywords:  HLA-DR; Molecular typing

Year:  2011        PMID: 27407382      PMCID: PMC4925343          DOI: 10.1016/S0377-1237(02)80129-0

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN: 0377-1237


  16 in total

1.  Molecular matching in renal transplantation.

Authors:  G Bein; R Gläser; T H Eiermann; J Hoyer; D Haase; H Kirchner
Journal:  Transplant Proc       Date:  1992-12       Impact factor: 1.066

2.  Application of HLA-DR oligotyping to 110 kidney transplant patients with doubtful serological typing.

Authors:  J M Tiercy; C Goumaz; B Mach; M Jeannet
Journal:  Transplantation       Date:  1991-05       Impact factor: 4.939

3.  Survival of DNA HLA-DR typed and matched cadaver kidney transplants. The Collaborative Transplant Study.

Authors:  G Opelz; J Mytilineos; S Scherer; H Dunckley; J Trejaut; J Chapman; D Middleton; D Savage; O Fischer; J D Bignon
Journal:  Lancet       Date:  1991-08-24       Impact factor: 79.321

4.  The large center variation in half-lives of kidney transplants.

Authors:  D W Gjertson; P I Terasaki
Journal:  Transplantation       Date:  1992-02       Impact factor: 4.939

5.  DNA typing for HLA-A and HLA-B identifies disparities between patients and unrelated donors matched by HLA-A and HLA-B serology and HLA-DRB1.

Authors:  V K Prasad; N A Kernan; G Heller; R J O'Reilly; S Y Yang
Journal:  Blood       Date:  1999-01-01       Impact factor: 22.113

6.  Comparison between HLA-DR serologic typing and oligotyping in kidney transplant: a single center experience.

Authors:  F Papola; M Valeri; N Torlone; L Provenzani; A Canossi; A Piazza; P I Monaco; D Maccarone; I Contasta; E Poggi
Journal:  Transplant Proc       Date:  1993-06       Impact factor: 1.066

7.  HLA-DR matching assessed by DNA analysis in kidney transplantation--a one-center study.

Authors:  J D Bignon; S Nataf; M Hourmant; A Cesbron; J P Soulillou; J Y Muller
Journal:  Transplant Proc       Date:  1993-02       Impact factor: 1.066

8.  Molecular compatibility and renal graft survival--the HLA DRB1 genotyping.

Authors:  S Hsia; J Y Tong; G L Parris; D D Nghiem; E M Cottington; W A Rudert; M Trucco
Journal:  Transplantation       Date:  1993-02       Impact factor: 4.939

9.  UCLA and UNOS Registries. Overview.

Authors:  P I Terasaki; J M Cecka; E Lim; S Takemoto; Y Cho; D Gjertson; K Ogura; H Koyama; Y Mitsuishi; J Yuge
Journal:  Clin Transpl       Date:  1991

Review 10.  Current methodologies of human leukocyte antigen typing utilized for bone marrow donor selection.

Authors:  A M Little; S G Marsh; J A Madrigal
Journal:  Curr Opin Hematol       Date:  1998-11       Impact factor: 3.284

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.